{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:52:34Z","timestamp":1792079554855,"version":"4.4.0"},"reference-count":9,"publisher":"American Society of Hematology","issue":"16","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,15]]},"DOI":"10.1182\/blood.2026035655","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:32:06Z","timestamp":1792078326000},"page":"1958-1959","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Taking the brakes off cytolytic CD4+ T cells"],"prefix":"10.1182","volume":"148","author":[{"given":"Tobias","family":"Wertheimer","sequence":"first","affiliation":[{"name":"University Medical Center Freiburg"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"16","key":"2026101511320080000_bib1","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1182\/blood.2025032420","article-title":"IL-6 receptor inhibition promotes expansion of cytolytic CD4+ T cells after cellular immunotherapy","volume":"148","author":"Williams","year":"2026","journal-title":"Blood"},{"issue":"6","key":"2026101511320080000_bib2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41591-018-0036-4","article-title":"Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells","volume":"24","author":"Norelli","year":"2018","journal-title":"Nat Med"},{"issue":"23","key":"2026101511320080000_bib3","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1182\/blood.2019000396","article-title":"IL-6 dysregulation originates in dendritic cells and mediates graft-versus-host disease via classical signaling","volume":"134","author":"Wilkinson","year":"2019","journal-title":"Blood"},{"issue":"8","key":"2026101511320080000_bib4","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1634\/theoncologist.2018-0028","article-title":"FDA approval summary: tocilizumab for treatment of chimeric antigen receptor T cell-induced severe or life-threatening cytokine release syndrome","volume":"23","author":"Le","year":"2018","journal-title":"Oncologist"},{"issue":"14","key":"2026101511320080000_bib5","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1182\/blood.2020009050","article-title":"A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin\/methotrexate GVHD prophylaxis","volume":"137","author":"Kennedy","year":"2021","journal-title":"Blood"},{"issue":"12","key":"2026101511320080000_bib6","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1016\/j.immuni.2025.09.004","article-title":"Eomesodermin+ CD4+ T cells are critical for curative immunotherapy outcomes","volume":"58","author":"Zhang","year":"2025","journal-title":"Immunity"},{"issue":"12","key":"2026101511320080000_bib7","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1016\/j.immuni.2021.11.015","article-title":"Cytotoxic CD4+ T cells in cancer: expanding the immune effector toolbox","volume":"54","author":"Oh","year":"2021","journal-title":"Immunity"},{"issue":"24","key":"2026101511320080000_bib8","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1182\/blood.2021011216","article-title":"Increased efficacy of dual proinflammatory cytokine blockade on acute GVHD while maintaining GVT effects","volume":"138","author":"Khuat","year":"2021","journal-title":"Blood"},{"issue":"10","key":"2026101511320080000_bib9","doi-asserted-by":"crossref","first-page":"eaah7152","DOI":"10.1126\/sciimmunol.aah7152","article-title":"Eomesodermin promotes the development of type 1 regulatory T (TR1) cells","volume":"2","author":"Zhang","year":"2017","journal-title":"Sci Immunol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/16\/1958\/2594955\/blood_bld-2026-035655-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/16\/1958\/2594955\/blood_bld-2026-035655-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:32:07Z","timestamp":1792078327000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/148\/16\/1958\/571442\/Taking-the-brakes-off-cytolytic-CD4-T-cells"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":9,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2026,10,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2026035655","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10,15]]},"published":{"date-parts":[[2026,10,15]]}}}